Hyperthermic intra-peritoneal chemotherapy and anticancer immune response.
Oncoimmunology
; 5(1): e1060392, 2016.
Article
em En
| MEDLINE
| ID: mdl-26942072
ABSTRACT
Peritoneal carcinomatosis (PC) is a metastatic disease of primary tumors localized in the abdomen. Although this disease is considered a terminal condition, recent treatments combining surgery with heated intra-peritoneal chemotherapy (HIPEC) significantly increase patient survival. We have determined that the protective effect of HIPEC is partially linked to the induction of an efficient anticancer immune response.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article